Mare Ovulation Drug Gets FDA Approval
November 30, 2010
Thorn BioScience, a subsidiary of CreoSalus Inc., has received U.S. Food and Drug Administration approval for its SucroMate Equine, indicated to regulate ovulation in mares. The injection increases the likelihood of conception during breeding for both natural bred and artificially inseminated horses, according to the Louisville, Ky.-based company. It is the first FDA approved drug… Continue reading...